Tscan Therapeutics shares owned by Dean Capital Investments Management
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Dean Capital Investments Management
from 13F filings
Historical chart of Dean Capital Investments Management investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Dean Capital Investments Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tscan Therapeutics by Dean Capital Investments Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $91k | 36k | 2.56 |
2023-06-30 | $89k | 36k | 2.50 |
2023-03-31 | $75k | 36k | 2.10 |
2022-12-31 | $55k | 36k | 1.55 |
2022-09-30 | $110k | 36k | 3.09 |
2022-06-30 | $112k | 36k | 3.15 |
2022-03-31 | $100k | 36k | 2.81 |
2021-12-31 | $160k | 36k | 4.50 |
2021-09-30 | $297k | 36k | 8.35 |
More positions owned by Dean Capital Investments Management
View all positions for Dean Capital Investments Management